FOR IMMEDIATE RELEASE Contact: Berna Diehl Phone: 202-725-2553 Email: berna@brightoncomms.com Article by I-ACT for Children, other leading pediatric researchers stresses urgency in addressing the questions surrounding children and the disease Rockville, MD– Increasing reports of severe COVID-19 illness in children – coupled with the fact that little is known about how and why…
I-ACT for Children Launches Emergency Access Program to Speed Pediatric Clinical Trials for COVID-19
FOR IMMEDIATE RELEASE Contact: Berna Diehl Phone: 202-725-2553 Email: berna@brightoncomms.com Emergency program will allow any company developing COVID-19 treatments or vaccines to tap into pediatric global network, trial-planning experts Rockville, MD, – As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for…
The Institute for Advanced Clinical Trials (I-ACT) for Children is pleased to announce the appointment of Gary Noel, MD, as its Chief Medical Officer. Dr. Noel is a pediatrician, child advocate, specialist in Infectious Diseases and Immunology and a seasoned expert in drug development, having spent more than 30 years in leadership roles in the…
SHERATON SILVER SPRING | SILVER SPRING, MD SEPTEMBER 9, 2019 | 8:30 AM-4:30 PM I-ACT for Children will co-host the first Duchenne Muscular Dystrophy Platform Trial Community Meeting on Sept. 9 with collaborators Parent Project Muscular Dystrophy and the Critical Path Institute. The Duchenne Platform Trial is being designed to increase access to therapeutic trials…
I-ACT for Children has selected Advarra as the central IRB for the I-ACT for Children Clinical Trials Site Network – a geographically and therapeutically diverse network of pediatric trial sites committed to improving efficiencies and capabilities for the conduct of clinical trials. I-ACT for Children launched the central IRB function to streamline processes, expedite IRB…
Today I-ACT for Children welcomes Chiesi Group as our newest Annual Member. Click on the link below for more details. Full press release
We are thrilled to welcome Bayer AG as I-ACT for Children’s newest Annual Member! Click on the image below to read the full announcement.
We are delighted to announce that Eli Lilly and Company has joined I-ACT for Children as our newest Sustaining Member. Please click the image below for the press release and full details.
I-ACT for Children’s Dr. Carol Rosenberg (read full bio), Quality Improvement Project Manager, will co-lead a workshop at the International Meeting on Simulation in Healthcare (http://imsh2019.com/) on January 29th. Dr. Rosenberg will co-lead a workshop with Drs. Jennifer Arnold and Maria Carmen Diaz that focuses on the use of high-fidelity simulators to educate patients and their family…
We are thrilled to welcome Novartis as our newest sustaining member, click the image below to read the full press release.
